Alaunos Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Revenue	0.01	2.92	0.4	0	0	0.15	6.39	6.86	4.33	1.37	Upgrade
Revenue Growth (YoY)	-99.83%	634.17%	-	-	-	-97.71%	-6.88%	58.38%	215.51%	71.63%	Upgrade
Gross Profit	0.01	2.92	0.4	0	0	0.15	6.39	6.86	4.33	1.37	Upgrade
Selling, General & Admin	12.22	13.14	27.56	27.67	19.53	19.92	14.8	14.38	17.65	12.17	Upgrade
Research & Development	16.28	25.02	49.64	52.7	38.33	34.13	45.08	157.79	106.79	32.71	Upgrade
Other Operating Expenses	5.77	-0.13	0.74	0	0	0	0	0	0	0	Upgrade
Operating Expenses	34.27	38.03	77.95	80.36	57.86	54.05	59.88	172.17	124.43	44.87	Upgrade
Operating Income	-34.27	-35.11	-77.55	-80.36	-57.86	-53.91	-53.49	-165.31	-120.1	-43.5	Upgrade
Interest Expense / Income	1.92	3.15	1.19	0	0	0	0	0	0	0	Upgrade
Other Expense / Income	-1.05	-0.53	0.01	-0.39	59.94	-208.15	0.83	-0.01	-0.01	-11.72	Upgrade
Pretax Income	-35.14	-37.73	-78.75	-79.98	-117.8	154.24	-54.32	-165.3	-120.09	-31.78	Upgrade
Net Income	-35.14	-37.73	-78.75	-79.98	-117.8	154.24	-54.32	-165.3	-120.09	-31.78	Upgrade
Preferred Dividends	0	0	0	0	0	17	18.94	7.12	0	0	Upgrade
Net Income Common	-35.14	-37.73	-78.75	-79.98	-117.8	137.25	-73.26	-172.42	-120.09	-31.78	Upgrade
Shares Outstanding (Basic)	16	14	14	14	11	10	9	9	8	7	Upgrade
Shares Outstanding (Diluted)	16	14	14	14	11	10	9	9	8	7	Upgrade
Shares Change	10.50%	1.27%	2.27%	24.82%	16.87%	4.95%	5.02%	3.97%	24.01%	17.67%	Upgrade
EPS (Basic)	-2.20	-2.61	-5.55	-5.70	-10.50	14.40	-7.95	-19.80	-14.40	-4.65	Upgrade
EPS (Diluted)	-2.20	-2.61	-5.55	-5.70	-10.50	14.40	-7.95	-19.80	-14.40	-4.65	Upgrade
Free Cash Flow	-28.8	-29.43	-64.79	-66.79	-41.14	-49.92	-55.41	-58.88	-0.42	-36.84	Upgrade
Free Cash Flow Per Share	-1.80	-2.03	-4.53	-4.78	-3.67	-5.22	-6.07	-6.77	-0.05	-5.46	Upgrade
Gross Margin	100.00%	100.00%	100.00%	-	-	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-685340.00%	-1201.40%	-19484.67%	-	-	-36921.92%	-837.27%	-2409.37%	-2772.39%	-3168.17%	Upgrade
Profit Margin	-702800.00%	-1291.24%	-19786.68%	-	-	94004.11%	-1146.67%	-2513.04%	-2772.11%	-2314.71%	Upgrade
Free Cash Flow Margin	-575920.00%	-1007.02%	-16279.15%	-	-	-34189.04%	-867.21%	-858.13%	-9.74%	-2683.39%	Upgrade
EBITDA	-30.62	-31.33	-75.32	-78.85	-117.17	154.82	-53.95	-165.01	-119.73	-31.32	Upgrade
EBITDA Margin	-612360.00%	-1072.25%	-18923.87%	-	-	106040.41%	-844.48%	-2405.00%	-2763.87%	-2281.06%	Upgrade
Depreciation & Amortization	2.6	3.25	2.25	1.13	0.63	0.58	0.37	0.29	0.36	0.46	Upgrade
EBIT	-33.22	-34.58	-77.56	-79.98	-117.8	154.24	-54.32	-165.3	-120.09	-31.78	Upgrade
EBIT Margin	-664380.00%	-1183.30%	-19487.94%	-	-	105646.58%	-850.26%	-2409.23%	-2772.11%	-2314.71%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).